Kara A. Scheibner
FDA investigator
Appears on 1 document from 2026, mostly at sites in India. Most often cites retention of bioavailability samples (21 CFR 320.38).
- 1
- Documents on file
- 6.0
- Observations per 483
- 2026
- First seen
- 2026
- Most recent
What they cite most
From 6 observations- 21 CFR 320.38Retention of bioavailability samples1
- 21 CFR 50.20General requirements for informed consent1
- 21 CFR 50.25Elements of informed consent1
Activity by year
2026: 1
Where
India 1
Often inspects with
Is Kara A. Scheibner coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
1 document, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2026-04-17 | 483 Cliantha Research LimitedApr 17, 2026 · Ahmedabad, India | Ahmedabad, India | 6 |
About this profile
What does Kara A. Scheibner inspect?
Kara A. Scheibner appears on 1 document on file covering 1 site, mostly in India.
What do they cite most often?
21 CFR 320.38 (retention of bioavailability samples), followed by 21 CFR 50.20 and 21 CFR 50.25.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Kara A. Scheibner is dated Apr 17, 2026.